Hims & Hers Health’s (HIMS) Sell Rating Reiterated at Citigroup
Citigroup reiterated their sell rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report report published on Thursday,Benzinga reports. They currently have a $27.00 price objective on the stock. A number of other analysts have also recently weighed in on the stock. Canaccord Genuity Group upped their target price […]
Citigroup reiterated their sell rating on shares of Hims & Hers Health (NYSE:HIMS – Free Report) in a research report report published on Thursday,Benzinga reports. They currently have a $27.00 price objective on the stock. A number of other analysts have also recently weighed in on the stock. Canaccord Genuity Group upped their target price […]
